Facts
The Canadian Centre for Ethics in Sport (CCES) alleges Christopher Sheppard for a violation of the Canadian Anti-Doping Program (CADP). The athlete was selected for a no advance notice, out-of-competition doping control in Kamloops, British Columbia.
Pursuant to the rules of CADP the Athlete provided a urine sample for testing on 29 May 2005. His sample tested positive on the prohibited substance recombinant human erythropoietin (rhEPO). Also the B-sample tested positive on this substance.
History
This is the first Canadian doping case to deal with the Prohibited Substance rhEPO.
Decision
It has been established that a Prohibited Substance was present in Mr. Sheppard's urine sample. Therefore, an anti-doping rule violation has occurred under the CADP Rule 7.16. The Athlete raised no issue of no fault or negligence, or, any significant fault or negligence. Therefore, it is no required to examine the elimination or reduction of the sanction. In the circumstances, the imposed sanction for a first anti-doping rule violation of a two year period of ineligibility as provided for by Rule 7.20. CADP Rule 7.37 applies. Mr. Sheppard is from the date of this award permanently ineligible for direct financial support provided by the Government of Canada.
The foregoing period of ineligibility in respect of the sanction and the financial support starts on the date of this decision in accordance with the CADP.
Costs
No submission was made on costs. Unless applied for, no order in respect of the same will be made.
